Cargando…

Fast 3: a phase III randomized double-blind, placebo-controlled multicenter study of Icatibant for subcutaneous injection in patients with acute Attacks of Hereditary Angioedema (HAE)

Detalles Bibliográficos
Autor principal: Ritchie, B
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874297/
http://dx.doi.org/10.1186/1710-1492-6-S1-P27
_version_ 1782181453117784064
author Ritchie, B
author_facet Ritchie, B
author_sort Ritchie, B
collection PubMed
description
format Text
id pubmed-2874297
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28742972010-05-22 Fast 3: a phase III randomized double-blind, placebo-controlled multicenter study of Icatibant for subcutaneous injection in patients with acute Attacks of Hereditary Angioedema (HAE) Ritchie, B Allergy Asthma Clin Immunol Poster Presentation BioMed Central 2010-05-12 /pmc/articles/PMC2874297/ http://dx.doi.org/10.1186/1710-1492-6-S1-P27 Text en Copyright ©2010 Ritchie; licensee BioMed Central Ltd.
spellingShingle Poster Presentation
Ritchie, B
Fast 3: a phase III randomized double-blind, placebo-controlled multicenter study of Icatibant for subcutaneous injection in patients with acute Attacks of Hereditary Angioedema (HAE)
title Fast 3: a phase III randomized double-blind, placebo-controlled multicenter study of Icatibant for subcutaneous injection in patients with acute Attacks of Hereditary Angioedema (HAE)
title_full Fast 3: a phase III randomized double-blind, placebo-controlled multicenter study of Icatibant for subcutaneous injection in patients with acute Attacks of Hereditary Angioedema (HAE)
title_fullStr Fast 3: a phase III randomized double-blind, placebo-controlled multicenter study of Icatibant for subcutaneous injection in patients with acute Attacks of Hereditary Angioedema (HAE)
title_full_unstemmed Fast 3: a phase III randomized double-blind, placebo-controlled multicenter study of Icatibant for subcutaneous injection in patients with acute Attacks of Hereditary Angioedema (HAE)
title_short Fast 3: a phase III randomized double-blind, placebo-controlled multicenter study of Icatibant for subcutaneous injection in patients with acute Attacks of Hereditary Angioedema (HAE)
title_sort fast 3: a phase iii randomized double-blind, placebo-controlled multicenter study of icatibant for subcutaneous injection in patients with acute attacks of hereditary angioedema (hae)
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874297/
http://dx.doi.org/10.1186/1710-1492-6-S1-P27
work_keys_str_mv AT ritchieb fast3aphaseiiirandomizeddoubleblindplacebocontrolledmulticenterstudyoficatibantforsubcutaneousinjectioninpatientswithacuteattacksofhereditaryangioedemahae